BRCA1 and breast cancer: Only 1/204 patients (0.5%) who underwent RRM had a CBC in our study, but longer follow-up is necessary to assess the risk of developing breast cancer in the residual breast tissue after RRM, which is expected to be significantly lower than the annual 1–2% risk for breast cancer in the BRCA1/2 PV population without RRM [19].